Safe Pain Relief in Pregnancy

• Generally avoided as first choice, but may be used up to ~20 weeks if clinically indicated.
• Avoid after 20 weeks / in the third trimester: NSAIDs can cause fetal renal dysfunction leading to oligohydramnios (low amniotic fluid), and premature closure of the ductus arteriosus - Firestein & Kelley's Textbook of Rheumatology, p. 8337; Rosen's Emergency Medicine, p. 1531.
• Some epidemiologic data link early NSAID exposure to a modestly increased risk of miscarriage and rare defects (ventricular septal defects, gastroschisis), though evidence quality is mixed - Rosen's Emergency Medicine, p. 1531.
• Aspirin at analgesic/anti-inflammatory doses should also generally be avoided (low-dose 81mg aspirin for pre-eclampsia prophylaxis is a separate, distinct indication and is safe).

• Not first-line, but can be used when paracetamol +/- NSAID is insufficient.
• A 2024 systematic review/meta-analysis (Varney et al., Anaesthesia, PMID 38715235) found first-trimester opioid exposure was not associated with an overall increase in major congenital malformations (RR 1.04, 95% CI 0.98-1.11), though codeine specifically showed a small association with atrial septal defects (RR 1.20) and overall study quality was limited (high risk of bias in most studies).
• Key concerns are with use near delivery (neonatal respiratory depression, withdrawal/neonatal opioid withdrawal syndrome) and risk of maternal dependence with prolonged use. ACOG advises pregnancy itself should not be a reason to avoid treating acute pain, but opioids should be minimized in chronic pain management and used with shared decision-making.

1. Paracetamol for mild-moderate pain - safe at any stage.
2. Add NSAID only if needed and only before 20 weeks, for the shortest course.
3. If pain remains uncontrolled, a weak opioid (codeine, tramadol) short-course, then stronger opioids (morphine) only for severe pain, ideally under obstetric supervision, tapering off before stopping paracetamol/NSAIDs.

Latest Clinical Guidelines on Analgesia in Pregnancy

1. BMJ "10-Minute Consultation": Discussing and Prescribing Analgesia in Pregnancy (2026)

• Paracetamol is the safe, effective first-line analgesic throughout pregnancy, with no demonstrated risk of neurodevelopmental sequelae in offspring.
• Oral NSAIDs can be used in the first 20 weeks of pregnancy but are not recommended thereafter.
• Low-dose aspirin (up to 162 mg/day) is a distinct, separate recommendation - used for pre-eclampsia prevention in high-risk women, started before 16 weeks and continued until 36 weeks.
• Special populations (e.g. sickle cell disease with vaso-occlusive crisis) need individualized plans balancing NSAID benefits against later-pregnancy risk.

2. SOAP / SMFM / ASRA Multidisciplinary Consensus Statement (2025)

• Both SOAP and ACOG recommend scheduled NSAIDs plus acetaminophen as first-line multimodal analgesia after cesarean delivery (Class I, Level B-R), given well-established opioid-sparing effects.
• IV ketorolac for 24-48 hours post-cesarean, transitioning to oral ibuprofen.
• For patients with OUD, guidance covers prenatal optimization, labor analgesia, and postpartum pain control alongside medication for OUD (buprenorphine/methadone), emphasizing multidisciplinary, non-stigmatizing care.

3. SOGC Guideline No. 443b: Opioid Use in Pregnancy and Breastfeeding (2023)

• Recommends a trauma-informed, non-stigmatizing approach to opioid use in pregnancy.
• Opioid agonist therapy (methadone/buprenorphine) can be safely continued in pregnancy when disorder-related risks outweigh treatment risks.
• Addresses fetal development, neonatal abstinence syndrome, and breastfeeding considerations.

4. ACOG Clinical Practice Guideline No. 3: Headaches in Pregnancy and Postpartum (2022)

• Paracetamol remains first-line; specific guidance on triptan and NSAID use windows for migraine in pregnancy and lactation.

5. CDC/ACOG General Opioid Framework (2022 CDC Clinical Practice Guideline, referenced in current CDC clinical guidance)

• Pregnancy should not be a reason to avoid treating acute pain with opioids when indicated.
• For chronic pain, ACOG recommends avoiding or minimizing opioids, favoring multimodal non-opioid strategies.
• Postpartum pain management should follow a stepwise, multimodal, shared-decision-making approach.

Consistent themes across all current guidelines